About: Cost-Effectiveness Analysis of Trastuzumab (Herceptin) in HER2-Overexpressed Metastatic Breast Cancer   Goto Sponge  NotDistinct  Permalink

An Entity of Type : owl:Thing, within Data Space : data.idref.fr associated with source document(s)

AttributesValues
Author
Bibliographic Citation
  • Perez-Ellis Carole, Gonçalves Anthony, Jacquemier Jocelyne, Marty Michel, Girre Véronique, Roché Henri, Brain Etienne, Moatti Jean-Paul, Viens Patrice. Cost-Effectiveness Analysis of Trastuzumab (Herceptin) in HER2-Overexpressed Metastatic Breast Cancer. American Journal of Clinical Oncology, Lippincott, Williams & Wilkins, 2009, 32 (5), pp.492-498. ⟨10.1097/COC.0b013e3181931277⟩
  • Perez-Ellis Carole, Gonçalves Anthony, Jacquemier Jocelyne, Marty Michel, Girre Véronique, Roché Henri, Brain Etienne, Moatti Jean-Paul, Viens Patrice. Cost-Effectiveness Analysis of Trastuzumab (Herceptin) in HER2-Overexpressed Metastatic Breast Cancer. American Journal of Clinical Oncology, 2009, 32 (5), pp.492-498. ⟨10.1097/COC.0b013e3181931277⟩
Title
  • Cost-Effectiveness Analysis of Trastuzumab (Herceptin) in HER2-Overexpressed Metastatic Breast Cancer
dc:date
  • 2009
Digital Object Identifier (DOI)
  • 10.1097/COC.0b013e3181931277
Faceted Search & Find service v1.13.91 as of Aug 16 2018


Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software